Beta Bionics, Inc., a leader in diabetes management solutions, announced it will release its first quarter financial results for 2025 on May 6, 2025, after market close. Management will hold a ...

Net sales of $17.6 million, up 36% compared to $12.9 million in the first quarter of 2024. Durable Medical Equipment (DME) channel net sales of $13.8 million, up 14% compared to $12.1 million in the ...

I cannot think of a better choice than Bionic P&O as our first distributor for Ekso Indego Personal within the important orthotics and prosthetics industry.” “True innovation that supports patients in ...

Beta Bionics’ iLet insulin pump now counts an installed user base of more than 35K Beta Bionics Inc. Chief Executive Sean Saint described the first year of being a public company as a “rollercoaster.” ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended March 31, 2026 and ...